Literature DB >> 27506910

Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection.

Marco Pereira1, Renata Fialho2,3.   

Abstract

This study compared the quality of life (QoL) of HIV-infected patients with and without hepatitis C and examined the sociodemographic, HIV-related and psychological symptoms associated with the QoL domains in patients with HIV/HCV co-infection. The sample consisted of 248 HIV/HCV co-infected patients (18-74 years, 81.5 % male) and 482 patients only with HIV (24-78 years, 62.7 % male). Participants completed the WHOQOL-HIV-Bref questionnaire and the Brief Symptom Inventory. The HIV/HCV co-infected patients reported significantly lower QoL in all domains, as well as significantly lower scores in 10 of the 17 specific facets. Overall, among the co-infected patients, male gender, employment, combination antiretroviral therapy use and fewer depressive and anxiety symptoms were significantly associated with higher QoL. Symptoms of psychological distress accounted for significant variability in the QoL scores of co-infected patients. These data reinforce the need for tailored interventions to improve the overall well-being of HIV/HCV co-infected patients.

Entities:  

Keywords:  Co-infection; HCV; HIV; Psychological symptoms; Quality of life

Mesh:

Year:  2016        PMID: 27506910     DOI: 10.1007/s10865-016-9778-y

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  84 in total

1.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

2.  Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Herbert L Bonkovsky; Kristin K Snow; Peter F Malet; Carla Back-Madruga; Robert J Fontana; Richard K Sterling; Clark C Kulig; Adrian M Di Bisceglie; Timothy R Morgan; Jules L Dienstag; Marc G Ghany; David R Gretch
Journal:  J Hepatol       Date:  2006-11-27       Impact factor: 25.083

3.  Factor structure and psychometric properties of the European Portuguese version of a questionnaire to assess quality of life in HIV-infected adults: the WHOQOL-HIV-Bref.

Authors:  Maria C Canavarro; Marco Pereira
Journal:  AIDS Care       Date:  2011-11-22

4.  The burden of HCV treatment in patients with inherited bleeding disorders.

Authors:  D E Fransen van de Putte; K Fischer; D Posthouwer; E P Mauser-Bunschoten
Journal:  Haemophilia       Date:  2011-06-21       Impact factor: 4.287

5.  Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study.

Authors:  E G Bing; R D Hays; L P Jacobson; B Chen; S J Gange; N E Kass; J S Chmiel; S L Zucconi
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

6.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Authors:  Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

7.  Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Authors:  Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; Bruno Ledergerber; Jens Lundgren
Journal:  J Infect Dis       Date:  2005-08-11       Impact factor: 5.226

Review 8.  Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Authors:  Martin Vogel; Jürgen K Rockstroh
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

9.  The Lisbon Cohort of men who have sex with men.

Authors:  Paula Meireles; Raquel Lucas; Ana Martins; Ana Cláudia Carvalho; Ricardo Fuertes; João Brito; Maria José Campos; Luís Mendão; Henrique Barros
Journal:  BMJ Open       Date:  2015-05-12       Impact factor: 2.692

10.  Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Authors:  Rita Almeida Calado; Maria Raquel Rocha; Ricardo Parreira; João Piedade; Teresa Venenno; Aida Esteves
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

View more
  2 in total

1.  Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.

Authors:  Sonia Vibhakar Patel; Dushyantha T Jayaweera; Keri N Althoff; Joseph J Eron; Janna Radtchenko; Anthony Mills; Graeme Moyle; Steven Santiago; Paul E Sax; Jason Gillman; Karam Mounzer; Richard A Elion; Gregory D Huhn
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

2.  Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus.

Authors:  Evy Yunihastuti; Fhadilla Amelia; Arini Ika Hapsari; Bramantya Wicaksana; Veritea Natali; Alvina Widhani; Andri Sanityoso Sulaiman; Teguh Harjono Karjadi
Journal:  Health Qual Life Outcomes       Date:  2021-05-26       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.